| Name | Title | Contact Details |
|---|
Centre for Hip Health and Musculoskeletal Research is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
For more than 130 years, Boehringer Ingelheim has been committed to the research, development, and manufacturing of new medications with high therapeutic value for people and animals. As a family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in research and development. We are proud of addressing some of the most challenging healthcare issues. Our vision – value through innovation – has always characterized our collaborative work, and is for us simultaneously a fundamental requirement and a driving force. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees.
Sturgis Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sturgis, MI. To find more information about Sturgis Hospital, please visit www.sturgishospital.com
Eye Health Northwest is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.